WASHINGTON, DC. AUGUST 15, 2025 – Exiger applauds the White House’s Executive Order to fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) and strengthen Americans’ long-term access to essential medicines. For years, Exiger has worked across industry, Congress, and federal agencies to map and monitor the multi-tier pharmaceutical supply chains that underpin U.S. healthcare. Through 1Exiger, the AI analytics platform, Exiger has illuminated the risks posed by overreliance on foreign-sourced active pharmaceutical ingredients (APIs), including concentration risk, quality breakdowns, and the presence of unethical labor practices.
Brandon Daniels, CEO of Exiger, said: “This Executive Order moves the country from diagnosing the problem to building a buffer against it. By combining stockpiling with precise, data-driven visibility into where ingredients come from, policymakers and U.S. pharmaceutical manufacturers can target the right APIs, diversify away from single points of failure, and ensure that the medicines in our cabinets aren’t compromised by geopolitical leverage or unethical practices.”
Exiger’s latest report, A Bitter Pill: America’s Dangerous Dependence on China-Made Pharmaceuticals, offers an in-depth examination of the systemic vulnerabilities impacting U.S. drug security and outlines strategic policy pathways to strengthen domestic and allied manufacturing, diversify sourcing, and eliminate forced labor from supply chains.
About Exiger
Exiger is revolutionizing the way corporations, government agencies and banks navigate risk and compliance in their third-parties, supply chains and customers through its software and tech-enabled solutions. Exiger’s mission is to make the world a safer and more transparent place to succeed. Empowering its 550 customers across the globe, including 150 in the Fortune 500 and over 55 organizations across the Defense Industrial Base and government agencies, with award-winning AI technology, Exiger leads the way in ESG, cyber, financial crime, third-party and supply chain management and recently achieved FedRAMP® Moderate Authorization. Named one of Fast Company’s 2023 and 2024 ‘Brands That Matter’ and recipient of the Third Party Risk Association’s 2024 Innovator Award, Exiger’s work has been recognized by 50+ AI, RegTech and Supply Chain partner awards. Learn more at Exiger.com and follow Exiger on LinkedIn.
For more information, please contact:
Kody Gurfein
Chief Marketing Officer
1.914.393.0398
kgurfein@exiger.com
